Literature DB >> 17596516

A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway.

Shirin Kazemi1, Zineb Mounir, Dionissios Baltzis, Jennifer F Raven, Shuo Wang, Jothi-Latha Krishnamoorthy, Olivier Pluquet, Jerry Pelletier, Antonis E Koromilas.   

Abstract

Phosphoinositide-3 kinase (PI3K) plays an important role in signal transduction in response to a wide range of cellular stimuli involved in cellular processes that promote cell proliferation and survival. Phosphorylation of the alpha subunit of the eukaryotic translation initiation factor eIF2 at Ser51 takes place in response to various types of environmental stress and is essential for regulation of translation initiation. Herein, we show that a conditionally active form of the eIF2alpha kinase PKR acts upstream of PI3K and turns on the Akt/PKB-FRAP/mTOR pathway leading to S6 and 4E-BP1 phosphorylation. Also, induction of PI3K signaling antagonizes the apoptotic and protein synthesis inhibitory effects of the conditionally active PKR. Furthermore, induction of the PI3K pathway is impaired in PKR(-/-) or PERK(-/-) mouse embryonic fibroblasts (MEFs) in response to various stimuli that activate each eIF2alpha kinase. Mechanistically, PI3K signaling activation is indirect and requires the inhibition of protein synthesis by eIF2alpha phosphorylation as demonstrated by the inactivation of endogenous eIF2alpha by small interfering RNA or utilization of MEFs bearing the eIF2alpha Ser51Ala mutation. Our data reveal a novel property of eIF2alpha kinases as activators of PI3K signaling and cell survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596516      PMCID: PMC1951772          DOI: 10.1091/mbc.e07-01-0053

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  51 in total

1.  Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR.

Authors:  A H Wong; J E Durbin; S Li; T E Dever; T Decker; A E Koromilas
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

2.  Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Authors:  I Gout; G Middleton; J Adu; N N Ninkina; L B Drobot; V Filonenko; G Matsuka; A M Davies; M Waterfield; V L Buchman
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

3.  Heterologous dimerization domains functionally substitute for the double-stranded RNA binding domains of the kinase PKR.

Authors:  T L Ung; C Cao; J Lu; K Ozato; T E Dever
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

4.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis.

Authors:  D Scheuner; B Song; E McEwen; C Liu; R Laybutt; P Gillespie; T Saunders; S Bonner-Weir; R J Kaufman
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

Review 5.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 6.  Regulation of translation initiation by FRAP/mTOR.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

7.  Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells.

Authors:  S Gupta; S Stuffrein; R Plattner; M Tencati; C Gray; Y E Whang; E J Stanbridge
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies.

Authors:  I Mothe-Satney; G J Brunn; L P McMahon; C T Capaldo; R T Abraham; J C Lawrence
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

9.  Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase.

Authors:  B D Cuevas; Y Lu; M Mao; J Zhang; R LaPushin; K Siminovitch; G B Mills
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

10.  The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.

Authors:  M M Georgescu; K H Kirsch; T Akagi; T Shishido; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

View more
  50 in total

1.  eIF2α kinases control chalone production in Dictyostelium discoideum.

Authors:  Robert L Bowman; Yanhua Xiong; Janet H Kirsten; Charles K Singleton
Journal:  Eukaryot Cell       Date:  2011-01-28

2.  Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway.

Authors:  Zineb Mounir; Jothi Latha Krishnamoorthy; Shuo Wang; Barbara Papadopoulou; Shirley Campbell; William J Muller; Maria Hatzoglou; Antonis E Koromilas
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

3.  Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction.

Authors:  Young Mi Song; Sun-Ok Song; Yong-Keun Jung; Eun-Seok Kang; Bong Soo Cha; Hyun Chul Lee; Byung-Wan Lee
Journal:  Autophagy       Date:  2012-06-22       Impact factor: 16.016

4.  PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.

Authors:  Vivian R Ruvolo; Svitlana M Kurinna; Kul B Karanjeet; Todd F Schuster; Alberto M Martelli; James A McCubrey; Peter P Ruvolo
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

5.  Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response.

Authors:  Hiroaki Yamazaki; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Yasuhiro Tagawa; Maro Okamura; Ryouji Ogata; Tao Huang; Shotaro Nakajima; Jian Yao; Adrienne W Paton; James C Paton; Masanori Kitamura
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

6.  Translational control during endoplasmic reticulum stress beyond phosphorylation of the translation initiation factor eIF2α.

Authors:  Bo-Jhih Guan; Dawid Krokowski; Mithu Majumder; Christine L Schmotzer; Scot R Kimball; William C Merrick; Antonis E Koromilas; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

7.  The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer.

Authors:  Daniel J Inglis; Tina C Lavranos; Donna M Beaumont; Annabell F Leske; Chloe K Brown; Allison J Hall; Gabriel Kremmidiotis
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

8.  Phosphorylation of eIF2α at serine 51 is an important determinant of cell survival and adaptation to glucose deficiency.

Authors:  Hala Muaddi; Mithu Majumder; Philippos Peidis; Andreas I Papadakis; Martin Holcik; Donalyn Scheuner; Randal J Kaufman; Maria Hatzoglou; Antonis E Koromilas
Journal:  Mol Biol Cell       Date:  2010-07-21       Impact factor: 4.138

9.  Stress and IGF-I differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (pRB).

Authors:  Melissa Popowski; Heather A Ferguson; Amy M Sion; Erich Koller; Erik Knudsen; Carla L Van Den Berg
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

10.  Fatty acid-mediated endoplasmic reticulum stress in vivo: differential response to the infusion of Soybean and Lard Oil in rats.

Authors:  Angela M Nivala; Lauren Reese; Melinda Frye; Christopher L Gentile; Michael J Pagliassotti
Journal:  Metabolism       Date:  2013-01-10       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.